Blog
The 6 Biggest Bank Acquisitions in the First Half of 2021
There were plenty of bank mergers and acquisitions (M&A) in the first half of 2021, as M&A in the sector rebounded following a slowdown in 2020 due to the coronavirus pandemic. And while M&A this
Why the "Experts" Are Wrong About Stock Picking
Warren Buffett believes that individual investors are better off investing in low-cost index funds to mirror the market and ensure long-term profits than trying to pick stocks on their own. Fund
Crypto Is Everywhere. Does That Make Coinbase Stock a Buy?
If you are trying to figure out what a cryptocurrency is -- or why it's even remotely valuable -- rest easy: You aren't alone. While cutting-edge technologists have been pounding on the table for
3 Stocks to Watch Amid the China DiDi Selloff
Chinese ride-hailing company DiDi Global (NYSE: DIDI) has had an eventful public debut -- its shares have fallen by 20% just days after it completed its initial public offering. The stock plunged
Is Now the Time to Buy ChemoCentryx Stock?
Shares of the highly popular biotech stock ChemoCentryx (NASDAQ: CCXI) ticked up a few notches after a Wall Street analyst upgraded the stock to buy. Stifel analyst Dae Gon Ha thinks a recent
Is Bitcoin a Good Long-Term Investment?
The cryptocurrency market has been explosive this year, as more and more investors have rushed to get a piece of it. If you're thinking of putting money into cryptocurrency, you may specifically
3 of the Fastest-Growing Dividend Stocks on the Planet
For more than a decade, growth stocks have outperformed on Wall Street. The combination of historically low lending rates and ongoing quantitative easing measures from the nation's central bank have
Here's My Top Meme Stock Right Now
In a recent episode of The Rank on Fool Live, Fool.com contributor Matt Frankel, CFP, and chief growth officer Anand Chokkavelu ranked 10 of the most popular meme stocks in the market. While many
Is Trupanion Still a Buy After the Rally in June?
The announcement last month that pet insurance company Trupanion (NASDAQ: TRUP) was appointing 30-year animal health industry veteran Simon Wheeler as its first executive vice president of
Here's the Next Stock I'm Going to Buy
The stock market is one of the few places where there is less demand when prices get cheaper. That's because investors often fear that if prices are dropping, they will just fall more. That's a
With Ransomware Attacks on the Rise, These Cybersecurity Stocks Could Make You Rich
A recent flurry of cyberattacks has both the private sector and the U.S. government on edge, and for good reason. Many of these attacks involve ransomware, a type of malicious software designed to
Why We're Claiming Social Security at 62, 67, or 70
Social Security can be claimed between 62 and 70. There are pros and cons to filing for benefits at different ages, so it can be difficult to figure out what's best. In fact, my colleagues and I
Where Will ARK Genomic Revolution ETF Be in 5 Years?
Cathie Wood and her ARK Investment Management firm focus on areas of disruptive innovation. And few sectors have the potential to be more disruptive than genomics, where recent advancements are set
Robinhood Just Filed to Go Public: Here's What Investors Need to Know
Robinhood Markets, the commission-free stock trading and investing service, has been front and center in headlines in recent years -- for both good and bad reasons. While the app has helped
Could These Ultra-Popular Stocks Fall 90% (or More) in 1 Year? Wall Street Thinks So
For more than 15 months, investors have enjoyed a historic bounce-back rally from the coronavirus crash. Through the previous weekend, the widely followed S&P 500 had gained 95% since hitting its
Better Reddit Stock: Clover Health or Sundial Growers?
Reddit users have shone a spotlight on several stocks that have skyrocketed. You can put health insurer Clover Health Investments (NASDAQ: CLOV) and cannabis operator Sundial Growers (NASDAQ: SNDL)
How Is Moderna's COVID Vaccine Holding Up Against Variants?
The biggest COVID-19 story right now is the rise of new coronavirus strains, especially the highly contagious Delta variant. Moderna (NASDAQ: MRNA) recently reported data about its COVID vaccine and
Can CureVac Win Market Share With Only 48% Vaccine Efficacy?
CureVac (NASDAQ: CVAC) surprised investors a few weeks ago when it announced disappointing data from a trial of its mRNA vaccine candidate. Many expected the German biotech would follow in the
A Stock Market Crash Is Likely: 3 Winning Stocks to Buy When It Happens
Most investors aren't big fans of stock market crashes or steep corrections, but the reality is that one is very likely on its way.
Even though the benchmark S&P 500 (SNPINDEX: ^GSPC) has enjoyed a
3 Top Cannabis Stocks to Buy for July
With warm weather upon us and people in the U.S. eager to make up for lost time from last year, it'd be a shock if marijuana sales did anything other than surge. Canny cannabis investors are
3 Cryptocurrency Myths That Could Cost You Big Time
Cryptocurrency has made an enormous impact on the investing world over the past few months, and many investors have scrambled to jump on the bandwagon in hopes of getting rich.
While prices have
Is It Too Late to Buy Intellia Therapeutics?
Healthcare is undergoing a genomics revolution, and Intellia Therapeutics (NASDAQ: NTLA) is leading the way. Founded by Jennifer Doudna, who won the 2020 Nobel Prize in Chemistry for her CRISPR-Cas9
25% of Americans Expect No Social Security Benefits in Retirement
Millions of seniors today rely on Social Security to cover their living expenses. And many of today's workers are counting on those benefits to eventually help them pay the bills during retirement.
The Pentagon's JEDI Contract Is Dead -- but It Will Return
The Pentagon has pulled the plug on a controversial $10 billion enterprise cloud contract awarded to Microsoft (NASDAQ: MSFT), ending a four-year-old effort that has been stuck in neutral because of
Why TAL Education Group Shot 9% Skyward Today
The Chinese for-profit education sector is not popular with investors at the moment. This is a key reason why a contrarian buy into the sector from a notable institutional investor drove TAL


